3 Biotech Stocks That Could Double In 2026

Core Insights - The biotech sector has experienced a resurgence after a decade of stagnation, attracting increased investor interest [1] - Growth in other economic sectors has resulted in elevated valuations for those sectors compared to the biotech sector [1] Industry Summary - Investors are focusing on top biotech names in the market, indicating a shift in investment strategy towards biotech [1] - The current market conditions suggest that biotech valuations may appear more attractive relative to other sectors [1]